Cite

HARVARD Citation

    Van der Wiel, A. et al. (n.d.). OC-0562: Exploiting tumor DNA repair status and hypoxia with CP-506, a novel hypoxia-activated prodrug. Radiotherapy and oncology. pp. S313-S314. [Online]. 
  
Back to record